Economic Impact of Non-Medical Opioid Use in the United States
October 2019
The Society of Actuaries’ Mortality and Longevity Strategic Research Committee announce the release of a new report on the economic impact of non-medical opioid use in the United States. Performed by a Milliman team led by Stoddard Davenport with Alexandra Weaver and Matt Caverly, this study estimates the total economic burden of the opioid crisis in the United States from 2015 through 2018 and projects future costs of the opioid epidemic for 2019.
Bericht
Economic Impact of Non-Medical Opioid Use in the United States
Podcast
Economic Impact of Non-Medical Opioid Use in the United States
Thank You
The Sponsor would like to thank the individuals who served on the Project Oversight Group
Elizabeth Arias
Jean-Marc Fix
Sam Gutterman
Gina Guzman
Al Klein, Chairperson of the Project Oversight Group
Tom Kukla
Donna Megregian
Jim Toole
Amy Whinnett
Jan Schuh, SOA Sr. Research Administrator
Ronora Stryker, SOA Sr. Practice Research Actuary
Questions Or Comments?
Give us your feedback! Take a short survey on this report. Take Survey
If you have comments or questions, please send an email to research@soa.org